Use of weight-loss jabs has soared in the UK, with about 1.5 million people utilizing drugs such as Ozempic and Wegovy. New research indicates that these medications, which primarily mimic hormones managing blood sugar and appetite, not only promote fat loss but potentially weaken muscles. A study revealed a roughly 10 percent decrease in muscle mass due to the weight loss effects of Ozempic. These drugs are predominantly prescribed for diabetes but are also accessible for individuals with high body mass index (BMI).
A study that tested weight loss jabs on mice found that although muscle mass changes less than expected, muscles still get weaker and tissues like the liver also shrink.
Weight-loss injections, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion.
The medications, known as semaglutides, predominantly treat diabetes but are also available on the NHS or via private providers to help adults with a high body mass index (BMI).
The results of the study, published in the journal Cell Metabolism, revealed Ozempic-induced weight loss decreased muscle mass by about 10 percent.
Collection
[
|
...
]